[Clinical value of Neo-Gilurytmal in the treatment of arrhythmias].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000404:Ajmaline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D013607:Tablets
D000889:Anti-Arrhythmia Agents; D000644:Quaternary Ammonium Compounds; D013607:Tablets; D000404:Ajmaline
Wartość kliniczna leku Neo-Gilurytmal w zwalczaniu zaburzeń rytmu serca